About the Company
We do not have any company description for Turnstone Biologics Corp. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Turnstone Biologics Corp.
XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics
Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right - EMERYVILLE, Calif., Aug. 11, 2025 ...
Turnstone Biologics Corp. Reports Second Quarter 2024 ... - Nasdaq
--Turnstone Biologics Corp., a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating ...
Xoma Completes Merger with Turnstone Biologics Corp
Xoma ( ($XOMA) ) has issued an update. On August 11, 2025, XOMA Royalty Corporation completed its merger with Turnstone Biologics Corp., following ...
Turnstone Biologics Corp. Reports First Quarter 2025 ... - Morningstar
Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights Provided by GlobeNewswire May 8, 2025, 3:00:49 PM ...
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results ...
SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid ...
XOMA Royalty Corporation to Acquire Turnstone Biologics Corp ... - Nasdaq
XOMA Royalty Corporation and Turnstone Biologics Corp. have announced a merger agreement in which XOMA Royalty will acquire Turnstone for $0.34 in cash per share, along with one non-transferable ...
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 ...
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights Mar. 21, 2024 5:06 PM ET Turnstone Biologics Corp. (TSBX) ...
Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public ...
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing new medicines to ...
Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results ...
SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated ...
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 ...
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights PRESS RELEASE GlobeNewswire Mar. 21, 2024, 05:06 PM ...
Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results ...
Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights Turnstone Biologics Corp. - GlobeNewswire - Thu May 8, 5:00PM CDT ...
Similar Companies
Loading the latest forecasts...